Skip to main content
Basilea Pharmaceutica AG (SWX: BSLN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
45.40
-0.15 (-0.33%)
Sep 4, 2024, 5:30 PM CET

Basilea Pharmaceutica AG Market Cap

Basilea Pharmaceutica AG has a market cap or net worth of 552.12 million as of September 4, 2024. Its market cap has decreased by -1.42% in one year.

Market Cap
552.12M
Enterprise Value
601.60M
Revenue
149.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
45.40

Market Cap Chart

Since March 25, 2004, Basilea Pharmaceutica AG's market cap has increased from 533.29M to 552.12M, an increase of 3.53%. That is a compound annual growth rate of 0.17%.

History

DateMarket Cap% Change
Sep 4, 2024550.30M30.13%
Dec 29, 2023422.90M-22.52%
Dec 30, 2022545.84M12.62%
Dec 30, 2021484.67M-15.59%
Dec 30, 2020574.19M14.12%
Dec 30, 2019503.13M15.74%
Dec 28, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 30, 2015 Pro Pro
Dec 30, 2014 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition